Phase 4 Coronary Arterial Disease (CAD) Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
J.P.S Henriques300 enrolled1 locationNCT06916520
Recruiting
Phase 4
The Switching Antiplatelet-9 (SWAP-9) Study
Coronary Arterial Disease (CAD)
University of Florida90 enrolled1 locationNCT06588595
Recruiting
Phase 4
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Coronary Arterial Disease (CAD)Vulnerable Coronary PlaquesThin-cap fIbroatheroma
Beijing Anzhen Hospital2,190 enrolled1 locationNCT06855537
Recruiting
Phase 4
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
University of Florida40 enrolled1 locationNCT07025148
Recruiting
Phase 4
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment
Coronary Arterial Disease (CAD)
China National Center for Cardiovascular Diseases120 enrolled1 locationNCT07041359
Recruiting
Phase 4
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Coronary Arterial Disease (CAD)
VZW Cardiovascular Research Center Aalst46 enrolled1 locationNCT06864234